Cibi e Bevande
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2021
Accumulated revenue for January - February 2021 increased by 29% SEK 208.1 (161.9) million.
Revenues were distributed as follows:
- The Nordics: Denmark , Faroe Island,
Finland , Iceland ,
Norway , Sweden
- Central Europe :
Austria , Germany ,
Switzerland
- East Europe: Czech Republic ,
Slovakia , Hungary ,
Poland , Romania
- South & West Europe :
Cyprus , France ,
Greece , Italy ,
Netherlands , Spain ,
United Kingdom
- The Baltics: Estonia ,
Latvia , Lithuania
- North America: Canada ,
USA
- Asia-Pacific: Australia ,
Hong Kong , Malaysia ,
Singapore , Taiwan ,
Thailand
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com
Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino AB (publ.) är ett globalt företag inom direktförsäljning som marknadsför och säljer testbaserade kosttillskotts-, hudvårds- och livsstilsprodukter. Zinzino äger forskningsenheten BioActive Foods AS och produktionsenheten Faun Pharma AS. Zinzinos huvudkontor ligger i Göteborg, och företaget har även kontor i Finland , Lettland, Norge,
USA , Australien, Hongkong och
Malaysia . Zinzino är ett aktiebolag noterat på Nasdaq First North Premier Growth Market.
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 15:30 the 3rd of March 2021 .
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-february-2021,c3299682
The following files are available for download: